Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy

Drug-eluting stents (DES) reduce the incidence of in-stent restenosis (ISR) after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Whether the use of biomarkers might be of utility to identify patients who remain at risk for DES ISR after primary PCI h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2012-08, Vol.34 (2), p.165-179
Hauptverfasser:	Claessen, Bimmer E., Stone, Gregg W., Mehran, Roxana, Witzenbichler, Bernhard, Brodie, Bruce R., Wöhrle, Jochen, Witkowski, Adam, Guagliumi, Giulio, Zmudka, Krzysztof, Henriques, José PS, Tijssen, Jan GP, Sanidas, Elias A., Chantziara, Vasiliki, Hakim, Diaa, Leon, Selene, Xu, Ke, Dangas, George D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers - blood Cardiology Coronary Angiography Cytokines - blood Drug-Eluting Stents Female Follow-Up Studies Graft Occlusion, Vascular - blood Graft Occlusion, Vascular - diagnostic imaging Graft Occlusion, Vascular - therapy Hematology Humans Interleukin 1 Receptor Antagonist Protein - blood Interleukin-6 - blood Male Matrix Metalloproteinase 9 - blood Medicine Medicine & Public Health Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Myocardial Infarction - therapy Paclitaxel - pharmacology Peroxidase Placenta Growth Factor Pregnancy Proteins - blood Tubulin Modulators - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!